DSS Announces Update On the Acquisition of Impact Biomedical
ROCHESTER, N.Y., July 15, 2020 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (DSS or the Company) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, is pleased to announce an update of its impending acquisition of Impact BioMedical as outlined in the share exchange agreement (Transaction) announced on April 27, 2020, signed by DSS, DSS BioHealth Security, Inc. (a wholly-owned direct subsidiary of DSS), Impact BioMedical Inc. (Impact BioMedical) and Global BioMedical Pte.
- ROCHESTER, N.Y., July 15, 2020 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (DSS or the Company) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, is pleased to announce an update of its impending acquisition of Impact BioMedical as outlined in the share exchange agreement (Transaction) announced on April 27, 2020, signed by DSS, DSS BioHealth Security, Inc. (a wholly-owned direct subsidiary of DSS), Impact BioMedical Inc. (Impact BioMedical) and Global BioMedical Pte.
- Global BioMedical, which owns all of the stock of Impact BioMedical, is a 100% owned subsidiary of Singapore eDevelopment Limited (SeD) (SGX: 40V).
- The DSS long-term plans include seeking to take Impact BioMedical public after the share exchange in an initial public offering (IPO).
- Impact BioMedical, Inc. (Impact BioMedical) is a wholly owned direct subsidiary of Global BioMedical Pte.